CJC-1295/Ipamorelin is typically not covered by insurance
0.25 mg per injection Weeks 1 4 Frequency 1 / week Monthly Total 1.0 mg Purpose GI adaptation 0.25 mg/wk 0.5 mg per injection Weeks 5 8 Frequency 1 / week Monthly Total 2.0 mg Purpose Dose escalation 0.5 mg/wk 1.0 mg per injection Weeks 9 12 Frequency 1 / week Monthly Total 4.0 mg Purpose Therapeutic range 1.0 mg/wk 1.7 mg per injection Weeks 13 16 Frequency 1 / week Monthly Total 6.8 mg Purpose Continued escalation 1.7 mg/wk 2.4 mg per injection Week 17 onward Frequency 1 / week Monthly Total 9.6 mg Purpose Maintenance dose 2.4 mg/wk Pick Your Injection Day Cagrilintide is injected once per week on the same day
Strong oxidizers can degrade copper peptides
It does not provide preparation, dosing, injection, administration, cycling, stacking, purchasing or personal-use guidance
Reported TB-500 side effects include fatigue, headaches, injection-site reactions, and appetite changes, but human safety research is very limited